Literature DB >> 8387246

Abnormal chest x-rays in intravenous drug users: implications for tuberculosis screening programs.

E Bellin1, D Fletcher, S Safyer.   

Abstract

OBJECTIVES: The purpose of the study was to (1) determine the prevalence of significant abnormalities in routine chest x-rays used to screen for pulmonary tuberculosis in intravenous drug users and (2) evaluate the ability of the purified protein derivative skin test to identify persons with such abnormalities.
METHODS: We conducted a cross-sectional screening study on 1314 persons admitted to an opiate detoxification unit in an urban jail. Purified protein derivative tuberculin reactivity and the prevalence of abnormalities consistent with tuberculosis on screening chest x-rays were evaluated. The chest x-ray was obtained independent of the skin test.
RESULTS: The chest x-rays of 73 of the inmates (5.6%) showed abnormalities consistent with tuberculosis. Tuberculin skin testing missed 17 of 26 chest x-rays (65%) with significant infiltrates.
CONCLUSIONS: Purified protein derivative screening is insensitive to chest x-ray abnormalities that require additional diagnostic evaluation for tuberculosis. Routine chest studies should be performed on all intravenous drug users admitted to congregate housing settings.

Entities:  

Mesh:

Year:  1993        PMID: 8387246      PMCID: PMC1694693          DOI: 10.2105/ajph.83.5.698

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  13 in total

1.  Increasing incidence of tuberculosis in a prison inmate population. Association with HIV infection.

Authors:  M M Braun; B I Truman; B Maguire; G T DiFerdinando; G Wormser; R Broaddus; D L Morse
Journal:  JAMA       Date:  1989-01-20       Impact factor: 56.272

2.  Prevalence of tuberculin positivity and skin test anergy in HIV-1-seropositive and -seronegative intravenous drug users.

Authors:  N M Graham; K E Nelson; L Solomon; M Bonds; R T Rizzo; J Scavotto; J Astemborski; D Vlahov
Journal:  JAMA       Date:  1992-01-15       Impact factor: 56.272

3.  The multi-test system: a standardized approach to evaluation of delayed hypersensitivity and cell-mediated immunity.

Authors:  W T Kniker; C T Anderson; M Roumiantzeff
Journal:  Ann Allergy       Date:  1979-08

4.  Sputum induction by newer inhalation methods in patients with pulmonary tuberculosis.

Authors:  W Y Yue; S S Cohen
Journal:  Dis Chest       Date:  1967-06

5.  HIV-1 infection among New York City inmates.

Authors:  I B Weisfuse; B L Greenberg; S D Back; H A Makki; P Thomas; W C Rooney; E L Rautenberg
Journal:  AIDS       Date:  1991-09       Impact factor: 4.177

6.  Sputum induction by saline aerosol.

Authors:  E M Gatner; D Gärtig; H H Kleeberg
Journal:  S Afr Med J       Date:  1977-02-26

7.  Anergy in active pulmonary tuberculosis. A comparison between positive and negative reactors and an evaluation of 5 TU and 250 TU skin test doses.

Authors:  D R Nash; J E Douglass
Journal:  Chest       Date:  1980-01       Impact factor: 9.410

8.  Racial differences in susceptibility to infection by Mycobacterium tuberculosis.

Authors:  W W Stead; J W Senner; W T Reddick; J P Lofgren
Journal:  N Engl J Med       Date:  1990-02-15       Impact factor: 91.245

9.  Undetected tuberculosis in prison. Source of infection for community at large.

Authors:  W W Stead
Journal:  JAMA       Date:  1978-12-01       Impact factor: 56.272

10.  Assessment of delayed-type hypersensitivity in man: a comparison of the "Multitest" and conventional intradermal injection of six antigens.

Authors:  I H Frazer; E J Collins; J S Fox; B Jones; R C Oliphant; I R Mackay
Journal:  Clin Immunol Immunopathol       Date:  1985-05
View more
  2 in total

1.  Screening for tuberculosis in jail and clinic follow-up after release.

Authors:  J P Tulsky; M C White; C Dawson; T M Hoynes; J Goldenson; G Schecter
Journal:  Am J Public Health       Date:  1998-02       Impact factor: 9.308

2.  Sexual risk behavior of incarcerated, drug-using women, 1992.

Authors:  R Schilling; N el-Bassel; A Ivanoff; L Gilbert; K H Su; S M Safyer
Journal:  Public Health Rep       Date:  1994 Jul-Aug       Impact factor: 2.792

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.